Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BATMAN minocycline trial in cerebral amyloid angiopathy
NL-OMON54550Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of minocycline in cerebral amyloid angiopathy (CAA) and familial cerebral amyloid angiopathy (4 arms), sponsored by Leiden University Medical Center. Primary endpoint: Markers of neuroinflammation and the gelatinase pathway in the cerebrospinal fluid. Started Dec 2020; status: completed.
02
Drugs
minocycline
03
Conditions
cerebral amyloid angiopathy (CAA)familial cerebral amyloid angiopathy
Beyond the preview
Go deeper on NL-OMON54550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54550.